175 related articles for article (PubMed ID: 27442685)
21. An objective measure of growth rate using partial biopsy specimens of melanomas that were initially misdiagnosed.
Lin MJ; Mar V; McLean C; Kelly JW
J Am Acad Dermatol; 2014 Oct; 71(4):691-7. PubMed ID: 24976443
[TBL] [Abstract][Full Text] [Related]
22. The current management and prognosis of acral lentiginous melanoma.
Wells KE; Reintgen DS; Cruse CW
Ann Plast Surg; 1992 Jan; 28(1):100-3. PubMed ID: 1642394
[TBL] [Abstract][Full Text] [Related]
23. Melanoma of the lower extremities: foot site is an independent risk factor for clinical outcome.
Sanlorenzo M; Osella-Abate S; Ribero S; Marenco F; Nardò T; Fierro MT; Novelli M; Cervetti O; Bernengo MG; Quaglino P
Int J Dermatol; 2015 Sep; 54(9):1023-9. PubMed ID: 25660506
[TBL] [Abstract][Full Text] [Related]
24. Acral melanoma foot lesions. Part 2: clinical presentation, diagnosis, and management.
Desai A; Ugorji R; Khachemoune A
Clin Exp Dermatol; 2018 Mar; 43(2):117-123. PubMed ID: 29235153
[TBL] [Abstract][Full Text] [Related]
25. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
[TBL] [Abstract][Full Text] [Related]
26. The most common challenges in melanoma diagnosis and how to avoid them.
Marghoob AA; Changchien L; DeFazio J; Dessio WC; Malvehy J; Zalaudek I; Halpern AC; Scope A
Australas J Dermatol; 2009 Feb; 50(1):1-13; quiz 14-5. PubMed ID: 19178485
[TBL] [Abstract][Full Text] [Related]
27. Acral lentiginous melanoma: a clinicoprognostic study of 126 cases.
Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
Br J Dermatol; 2006 Sep; 155(3):561-9. PubMed ID: 16911282
[TBL] [Abstract][Full Text] [Related]
28. Determinants of unfavorable presentation of primary cutaneous melanoma.
Fallah M; Kharazmi E; Thomsen H; Sundquist J; Hemminki K
J Am Acad Dermatol; 2011 Jul; 65(1):e5-6. PubMed ID: 21679807
[No Abstract] [Full Text] [Related]
29. The heel amelanotic melanoma, a rare subtype of skin cancer misdiagnosed as foot ulcer: A case report.
Hakamifard A; Mohaghegh F; Shabib S; Larki-Harchegani A; Eshraghi Samani R
Int Wound J; 2020 Jun; 17(3):819-822. PubMed ID: 32160649
[TBL] [Abstract][Full Text] [Related]
30. Melanoma mimicking plantar wart.
McBurney EI; Herron CB
J Am Acad Dermatol; 1979 Aug; 1(2):144-6. PubMed ID: 521512
[TBL] [Abstract][Full Text] [Related]
31. Plantar malignant melanoma -- a challenge for early recognition.
Franke W; Neumann NJ; Ruzicka T; Schulte KW
Melanoma Res; 2000 Dec; 10(6):571-6. PubMed ID: 11198479
[TBL] [Abstract][Full Text] [Related]
32. [The acrolentiginous melanoma: how to recognise and when to refer?].
Wouters LT; Thissen MR
Ned Tijdschr Geneeskd; 2012; 156(34):A4927. PubMed ID: 22914059
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological features and clinical outcomes associated with TP53 and BRAF
Kim DW; Haydu LE; Joon AY; Bassett RL; Siroy AE; Tetzlaff MT; Routbort MJ; Amaria RN; Wargo JA; McQuade JL; Kemnade J; Hwu P; Woodman SE; Roszik J; Kim KB; Gershenwald JE; Lazar AJ; Davies MA
Cancer; 2017 Apr; 123(8):1372-1381. PubMed ID: 27911979
[TBL] [Abstract][Full Text] [Related]
34. The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group study.
Oude Ophuis CM; Verhoef C; Rutkowski P; Powell BW; van der Hage JA; van Leeuwen PA; Voit CA; Testori A; Robert C; Hoekstra HJ; Grünhagen DJ; Eggermont AM; van Akkooi AC
Eur J Surg Oncol; 2016 Dec; 42(12):1906-1913. PubMed ID: 27266406
[TBL] [Abstract][Full Text] [Related]
35. "The malignant wart": a review of primary nodular melanoma of the foot and report of two cases.
Schade VL; Roukis TS; Homann JF; Brown T
J Foot Ankle Surg; 2010; 49(3):263-73. PubMed ID: 20605563
[TBL] [Abstract][Full Text] [Related]
36. Population-based incidence and melanoma-specific survival of cutaneous malignant melanoma in a Colombian population 2000-2009.
Reyes E; Uribe C; de Vries E
Int J Dermatol; 2018 Jan; 57(1):21-27. PubMed ID: 29231241
[TBL] [Abstract][Full Text] [Related]
37. Clinical outcomes of localized melanoma of the foot: a case-control study.
Talley LI; Soong S; Harrison RA; McCarthy WH; Urist MM; Balch CM
J Clin Epidemiol; 1998 Oct; 51(10):853-7. PubMed ID: 9762878
[TBL] [Abstract][Full Text] [Related]
38. Acral melanoma of the hallux.
Gentileschi S; D'Ettorre M; Tambasco D; Bracaglia R; Santoro A
Eur Rev Med Pharmacol Sci; 2015; 19(2):280-3. PubMed ID: 25683942
[TBL] [Abstract][Full Text] [Related]
39. Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of the SEER Registry.
Huang K; Fan J; Misra S
J Surg Res; 2020 Jul; 251():329-339. PubMed ID: 32208196
[TBL] [Abstract][Full Text] [Related]
40. Melanoma of the foot.
Barnes BC; Seigler HF; Saxby TS; Kocher MS; Harrelson JM
J Bone Joint Surg Am; 1994 Jun; 76(6):892-8. PubMed ID: 8200896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
